This is reminiscent of findings in a larger cohort study, where patients with DNMT3A and PPM1D single and co-mutated CH had reduced stem cell yields and delayed platelet count recovery following ASCT [18]. This evidence concerns the gene DNMT3A and cyclic hematopoiesis.